↓ Skip to main content

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.

Overview of attention for article published in Nutrición Hospitalaria, August 2015
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.
Published in
Nutrición Hospitalaria, August 2015
DOI 10.3305/nh.2015.32.2.9111
Pubmed ID
Authors

Dalila Pinto de Souza Fernandes, Fabiane Aparecida Canaan Rezende, Gabriele Pereira Rocha, Mariana De Santis Filgueiras, Patrícia Regina Silva Moreira, Rita de Cássia Gonçalves Alfenas

Abstract

there is a lack of consensus on the benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementations on cognition in dementia and/or Alzheimer's disease (AD) elderly. this study presents a systematic review of the results of randomized clinical trials about this topic. The adopted search criteria were randomized clinical trials involving elderly over 65 years of age with no limit to the year of publication of the study. we identified 139 articles, and from the eligible ones a reverse search was conducted. The quality of the trials was assessed using the Jadad scale. Of the four selected studies, three were related to mild to moderate AD elderly, of both genders. Mini Mental State Examination, Alzheimer's Disease Assessment Scale Cognitive, and Clinical Dementia Rate were the main tests used to assess cognitive performance. EPA and/or DHA supplementations did not affect scores obtained on the cognitive tests. However, supplementation with EPA and/or DHA improved verbal fluency and attention in patients who had only very mild dementia or AD or presented APOEε4 negative genotype. In case of advanced AD elderly patients, EPA and/or DHA supplementations did not reduce cognitive decline rates.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Greece 1 1%
Unknown 78 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 22%
Student > Master 11 14%
Other 6 8%
Student > Postgraduate 6 8%
Researcher 4 5%
Other 13 16%
Unknown 22 28%
Readers by discipline Count As %
Medicine and Dentistry 19 24%
Nursing and Health Professions 11 14%
Agricultural and Biological Sciences 8 10%
Psychology 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 9 11%
Unknown 23 29%